1157 related articles for article (PubMed ID: 15912436)
41. Implications of the natriuretic peptide system in the pathogenesis of heart failure: diagnostic and therapeutic importance.
Abassi Z; Karram T; Ellaham S; Winaver J; Hoffman A
Pharmacol Ther; 2004 Jun; 102(3):223-41. PubMed ID: 15246247
[TBL] [Abstract][Full Text] [Related]
42. Comparison of soluble glycoprotein 130 and cardiac natriuretic peptides as long-term predictors of heart failure progression.
Gwechenberger M; Pacher R; Berger R; Zorn G; Moser P; Stanek B; Huelsmann M
J Heart Lung Transplant; 2005 Dec; 24(12):2190-5. PubMed ID: 16364870
[TBL] [Abstract][Full Text] [Related]
43. [Clinical utility of NT-proBNP, a new biomarker of cardiac function and heart failure].
Ishii J
Rinsho Byori; 2008 Apr; 56(4):316-21. PubMed ID: 18516966
[TBL] [Abstract][Full Text] [Related]
44. Alternate circulating pro-B-type natriuretic peptide and B-type natriuretic peptide forms in the general population.
Lam CS; Burnett JC; Costello-Boerrigter L; Rodeheffer RJ; Redfield MM
J Am Coll Cardiol; 2007 Mar; 49(11):1193-202. PubMed ID: 17367664
[TBL] [Abstract][Full Text] [Related]
45. BNP as a biomarker in heart disease.
Vuolteenaho O; Ala-Kopsala M; Ruskoaho H
Adv Clin Chem; 2005; 40():1-36. PubMed ID: 16355919
[TBL] [Abstract][Full Text] [Related]
46. The prognostic value of N-terminal proB-type natriuretic peptide.
Costello-Boerrigter LC; Burnett JC
Nat Clin Pract Cardiovasc Med; 2005 Apr; 2(4):194-201. PubMed ID: 16265483
[TBL] [Abstract][Full Text] [Related]
47. [Comparison study on diagnostic and prognostic value of N-terminal pro-brain natriuretic peptide and atrium natriuretic peptide in chronic congestive heart failure].
Li YJ; Wang L; Chen KY; Chen YL; Cai JR; Zhou LJ
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2005 Sep; 17(9):544-7. PubMed ID: 16146600
[TBL] [Abstract][Full Text] [Related]
48. [The diagnostic value of N-terminal probrainnatriuretic peptide in patients with dyspnea].
Zhu Y; Cai B; Wang LL
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 May; 39(3):458-60. PubMed ID: 18575341
[TBL] [Abstract][Full Text] [Related]
49. The role of BNP testing in heart failure.
Doust J; Lehman R; Glasziou P
Am Fam Physician; 2006 Dec; 74(11):1893-8. PubMed ID: 17168346
[TBL] [Abstract][Full Text] [Related]
50. [Comparison study on diagnostic and prognostic value of N-terminal probrain natriuretic peptide and atrium natriuretic peptide in chronic congestive heart failure].
Dong H; Chen DQ; Wang Y; Li M
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(9):1740-2. PubMed ID: 18819908
[TBL] [Abstract][Full Text] [Related]
51. Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease.
Neuhold S; Huelsmann M; Strunk G; Stoiser B; Struck J; Morgenthaler NG; Bergmann A; Moertl D; Berger R; Pacher R
J Am Coll Cardiol; 2008 Jul; 52(4):266-72. PubMed ID: 18634981
[TBL] [Abstract][Full Text] [Related]
52. Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study.
Anwaruddin S; Lloyd-Jones DM; Baggish A; Chen A; Krauser D; Tung R; Chae C; Januzzi JL
J Am Coll Cardiol; 2006 Jan; 47(1):91-7. PubMed ID: 16386670
[TBL] [Abstract][Full Text] [Related]
53. [BNP or NT-proBNP: "that is the question"].
Lebrun C; Neuder Y; Pison C; Chouri N; Barnoud D; Belle L; Beaune G
Ann Biol Clin (Paris); 2007; 65(5):533-8. PubMed ID: 17913672
[TBL] [Abstract][Full Text] [Related]
54. N-terminal pro-B-type natriuretic peptide testing improves the management of patients with suspected acute heart failure: primary results of the Canadian prospective randomized multicenter IMPROVE-CHF study.
Moe GW; Howlett J; Januzzi JL; Zowall H;
Circulation; 2007 Jun; 115(24):3103-10. PubMed ID: 17548729
[TBL] [Abstract][Full Text] [Related]
55. [Usefulness of B-type natriuretic peptide (BNP) for the diagnosis of new-onset heart failure with a preserved left ventricular systolic function in longstanding hypertensive patients with acute dyspnea].
Arquès S; Roux E; Sbragia P; Pieri B; Gélisse R; Luccioni R; Ambrosi P
Arch Mal Coeur Vaiss; 2007 Feb; 100(2):113-20. PubMed ID: 17474496
[TBL] [Abstract][Full Text] [Related]
56. Brain natriuretic peptide and N-terminal pro-B-type natriuretic peptide show a different profile in response to acute decompensated heart failure treatment.
Di Somma S; Magrini L; Tabacco F; Marino R; Talucci V; Marrocco F; Cardelli P; Ferri E; Pittoni V
Congest Heart Fail; 2008; 14(5):245-50. PubMed ID: 18983287
[TBL] [Abstract][Full Text] [Related]
57. [Dyspnea and normal systolic function].
Hasenfuss G; Hermann HP; Pieske B
Herz; 2004 Sep; 29(6):602-8. PubMed ID: 15912435
[TBL] [Abstract][Full Text] [Related]
58. B-type natriuretic peptide and amino terminal proBNP predict one-year mortality in short of breath patients independently of the baseline diagnosis of acute destabilized heart failure.
Gegenhuber A; Mueller T; Dieplinger B; Poelz W; Pacher R; Haltmayer M
Clin Chim Acta; 2006 Aug; 370(1-2):174-9. PubMed ID: 16600203
[TBL] [Abstract][Full Text] [Related]
59. N-terminal prohormone brain natriuretic peptide as a marker for detecting low functional class patients and candidates for cardiac transplantation: linear correlation with exercise tolerance.
Kallistratos MS; Dritsas A; Laoutaris ID; Cokkinos DV
J Heart Lung Transplant; 2007 May; 26(5):516-21. PubMed ID: 17449423
[TBL] [Abstract][Full Text] [Related]
60. Screening the population for left ventricular hypertrophy and left ventricular systolic dysfunction using natriuretic peptides: results from the Dallas Heart Study.
de Lemos JA; McGuire DK; Khera A; Das SR; Murphy SA; Omland T; Drazner MH
Am Heart J; 2009 Apr; 157(4):746-53.e2. PubMed ID: 19332205
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
